The Pharma Bridge PhD Program of the Faculty of Pharmacy at the University of Pécs targets domestic partner organizations and professionals already active in the labor market. Within our program, we invite practicing professionals interested in scientific degree acquisition to join the "Optimizing Drug Therapy" program of the Doctoral School of Pharmaceutical Sciences.
It is less known to many that employees can pursue their doctoral studies under state-funded scholarships, receiving a monthly stipend of 140,000 HUF alongside their market salary. Additionally, participants in the Pharma Bridge PhD Program from the Faculty of Pharmacy are eligible for the PTE-UQA Supplementary Doctoral Student Scholarship ranging from 60,000 to 100,000 HUF monthly, which candidates can apply for every autumn by specific deadlines.
The doctoral (PhD) program not only equips candidates with research competencies but also fosters their ability to conduct independent research, enhances their understanding and processing of complex problems, and develops skills in forming independent opinions and engaging in professional public discourse. These experiences, skills gained during the program, and the networking opportunities with both academic and corporate sectors mutually benefit all parties involved.
The leadership and community of the Faculty of Pharmacy at the University of Pécs are committed to expanding the number of colleagues in pharmaceutical supply, the pharmaceutical industry, and research, development, and innovation, who seek to enrich their daily professional knowledge with the latest scientific research results, while being committed to the societal and economic utilization of their knowledge and skills.
Key Information:
- Applications must be submitted to the Doctoral (PhD) and Habilitation Office of the Faculty of Medicine. The current application deadlines for state-funded PhD programs can be found on the office's website.
- PhD candidates can choose topics from the advertised PhD programs of the Faculty of Medicine, as well as propose new market/industry-focused PhD topics, which must be submitted to the supervising professor by the end of April.
- In addition to an academic supervisor, an external co-supervisor who holds a PhD and is a colleague/supervisor at the workplace can also be appointed. If the external co-supervisor is not part of the doctoral program, their application must be submitted to the head of the doctoral council by the end of April.
- Research and development activities based on close collaboration can be carried out both at the university and at the workplace. Details of this collaboration should be agreed upon and documented in writing between the candidate and the supervising professor.
- Participants in the Pharma Bridge PhD Program from the Faculty of Pharmacy attend PhD courses announced by the doctoral school. They may also engage as instructors in the Faculty of Pharmacy's educational programs, which must be detailed in the PhD training plan and coordinated with the workplace supervisor.
- Due to the nature of industrial work or the research topic, confidentiality details, if justified, must be established in advance.
- At the time of application, the candidate and the supervisor(s) must declare that they will submit at least one KDP application (NKFIH Cooperative Doctoral Program) during the first two years of their PhD studies.
- Further details are available on the website of the Doctoral (PhD) and Habilitation Office. For any questions, please contact our faculty staff.